CPI Aerostructures (CVU)
Identity
Ticker: CVU | Exchange: NYSE American | Sector: Industrials — Aerospace & Defense HQ: 91 Heartland Blvd, Edgewood, NY 11717 | Founded: 1980 | IPO: 1992 Website: cpiaero.com | IR: investors.cpiaero.com Employees: ~212 (Feb 2026) | Market cap: ~$59M | EV: ~$74-84M
CPI Aerostructures builds the structural skeleton of military aircraft, electronic warfare pods, helicopters, and missiles. They're a contract manufacturer — the primes (Raytheon, Lockheed Martin, Northrop Grumman, L3Harris) design the systems, CPI builds the physical structures that house them. Think of it like being the general contractor who builds the house frame, except the "house" is a pod that jams enemy radar from an EA-18G Growler flying at 40,000 feet.
They sit as a Tier 1/Tier 2 supplier and occasional prime contractor to the DoD. Their sweet spot is complex, lower-volume structural work that the big primes don't want to do in-house — too small for Spirit AeroSystems but too specialized for a generic machine shop. Revenue is ~80% defense, ~20% commercial. Also makes engine inlet assemblies for Embraer business jets and RF/EMI shielded enclosures through subsidiary Compac Development Corporation.
One sentence: CPI builds the bones of military aircraft, EW pods, and missiles for defense primes like Raytheon and Lockheed Martin.
Thesis
Category: Turnaround / special situation
Core thesis: CPI Aerostructures is a micro-cap defense manufacturer with a massive $510M backlog (6x+ revenue), locked into multi-year production positions on growing programs (NGJ-MB electronic warfare pods, F-16 Block 70/72 exports, NGJ-LB, missile assemblies), and normalized margins of 20-22% gross / 7-9% EBIT. The stock is temporarily depressed by a one-time $8.1M A-10 program writeoff that crushed 2025 earnings. The market is treating this as permanent impairment rather than what it is — a one-time, non-recurring hit. As clean quarters accumulate and NGJ-MB production ramps through 2026-2027, the stock should re-rate.
The single most important thing that must go right: NGJ-MB pod production must ramp as expected, converting the growing backlog into revenue at normalized margins. If NGJ-MB stalls or is cut, the thesis falls apart.
Valuation snapshot (mid-March 2026):
| Metric | Value |
|---|---|
| Stock price | ~$4.47 |
| Market cap | ~$59M |
| Enterprise value | ~$74-84M |
| P/E (FY2024 normalized, $0.29 EPS) | ~16x |
| EV/EBITDA (FY2024, $7.8M adj) | ~9.5-10.8x |
| EV/Revenue (LTM) | ~1.0-1.2x |
| FCF yield (FY2024) | ~5.4% |
| 52-week range | $2.02 -- $5.40 |
Target price: $6.50-7.50 (45-68% upside) based on 10-12x normalized EBITDA of ~$8-9M Bear case: $2.00-2.50 (~40-45% downside) at 8x depressed EBITDA of ~$5-6M Risk/reward: Roughly 2:1 upside vs. downside. Not asymmetric enough for high conviction, but attractive for a moderate position.
Peer discount:
| Metric | CVU | Triumph (TGI) | Ducommun (DCO) | Sector Avg |
|---|---|---|---|---|
| EV/EBITDA | ~10x | ~13x | ~12x | ~12-15x |
| EV/Revenue | ~1.1x | ~2.0x | ~2.5x | ~2-3x |
| P/E | ~16x (norm) | ~25x | ~28x | ~20-25x |
CVU trades at a 40-50% discount to peers on every metric. Some of the discount is deserved (smaller, less diversified, SEC history), but the magnitude is excessive given backlog strength and margin improvement.
Business
Business Model
Pure contract manufacturing. Revenue is earned on long-term production contracts (fixed-price and cost-plus), recognized over time using cost-to-cost method (percentage of completion). No SaaS, no licensing, no recurring revenue in the traditional sense — but defense production contracts are inherently multi-year with strong visibility. Gross margins run 19-22% normalized, EBIT margins 7-9%.
Key Business Lines
| Segment | Description | ~% Revenue |
|---|---|---|
| Defense Aerostructures | Wing structures, control surfaces, rudder assemblies for F-16, E-2D, T-38, B-52, UH-60, CH-53, F-35 | ~55% |
| EW/ISR Pod Systems | Pod structures + Air Management Systems for NGJ-MB (Raytheon), NGJ-LB (L3Harris) | ~25% |
| Commercial Aerospace | Embraer Phenom 300 engine inlets, Gulfstream G650/G700, S-92 helicopter | ~15% |
| RF/EMI Enclosures | Shielded enclosures via Compac subsidiary (Collins Aerospace) | ~5% |
How the Product Works
Aerostructure manufacturing is applied materials science and precision metalworking:
- Structural loads: Components must withstand tensile, compressive, shear, and fatigue loads. Materials selected for strength-to-weight: aluminum alloys (6061, 7075) are workhorses; titanium (Ti-6Al-4V) for heat resistance; high-strength steels for structural joints; nickel alloys for engine-adjacent components.
- Fatigue life: Aircraft structures experience millions of load cycles. Understanding fatigue crack propagation (Paris' Law) and designing for damage tolerance is fundamental.
- EMI shielding: For EW pods, the structure must shield internal electronics from external electromagnetic interference while allowing jammer signals through designated apertures. Applied Faraday cage principles at aircraft-grade quality.
Key terminology:
- Build-to-print (BTP): Manufacturing to customer's drawings with no design responsibility
- Build-to-spec (BTS): Manufacturing to performance spec with some engineering freedom
- EAC (Estimate at Completion): Projected total cost of contract; directly affects margin recognition. Getting EACs wrong caused CPI's historical restatements.
- NTE (Not-to-Exceed): Maximum contract value
- AMS (Air Management System): Thermal/cooling system inside EW pods that keeps electronics at operating temperature
Product Deep-Dive: Key Programs
NGJ-MB Pod Structures & AMS (Raytheon) — The crown jewel. Replaces the aging ALQ-99 tactical jamming system on EA-18G Growlers. CPI builds the pod structure (physical housing) and Air Management System. Navy declared IOC December 2024; full-rate production ahead. Production is escalating: Lot 4 ($33.4M) to Lot 5 ($42.3M NTE) to follow-on orders ($12M NTE). CPI is the incumbent — switching mid-production would be enormously costly. Foreign military sales potential (Australia operates Growlers).
NGJ-LB Pod Structures (L3Harris) — Low-Band variant, L3Harris is prime (different from Raytheon on Mid-Band). $12.1M NTE, awarded Dec 2024, deliveries 2025-2027. Operational prototype phase; early operational capability expected 2029. Diversifies CPI beyond Raytheon on the pod side.
F-16 Block 70/72 RI/DCC Assemblies (Lockheed Martin) — Rudder Island / Drag Chute Canister assemblies for new-build export fighters. $9M in recent orders; deliveries through 2028. Strong demand from Taiwan, Bulgaria, Slovakia, Bahrain, Morocco.
E-2D Advanced Hawkeye Wing Kits (Northrop Grumman) — Historical total value $70M+. Mature program, steady-state production, declining contributor as E-2D winds down.
Missile Wing Assemblies (Raytheon) — New program win for undisclosed missile platform. Deliveries starting 2026. Diversification into guided munitions, market booming from Ukraine inventory drawdowns.
Embraer Phenom 300 Engine Inlets — $4.2M order Feb 2026, ongoing relationship. One of the best-selling light jets globally. Provides commercial cycle diversification.
RF/EMI Shielded Enclosures (Compac / Collins Aerospace) — Follow-on orders through mid-2027. Small but steady.
Operations Footprint
Single facility in Edgewood, Long Island, NY — 171,000 sq ft of manufacturing, assembly, paint, and office space. Computer-controlled paint booths, polishing centers, tube bending, welding, wire harness fabrication. In 2021, received $2.7M in Excelsior Jobs tax credits + $1.05M ESD capital grant, with $5.7M equipment investment and 85-job commitment.
Asset-light model: Capex runs $0.1-0.4M/year — extraordinary capex efficiency for a manufacturer. Generates ~$80M revenue from $0.4M annual capex. The real value is labor force, engineering know-how, certifications, and contract positions. Single-facility is both strength (efficiency) and risk (no redundancy).
No joint ventures. No strategic equity partnerships. Key relationships are long-term supply agreements.
Value Chain Position
[Raw Materials: Al, Ti, Steel] -> [CPI Aero: Structural Assembly] -> [Defense Primes: Systems Integration] -> [DoD / End Users]
Raytheon, Lockheed, Northrop, L3Harris
TAM & Market Position
- TAM: Global aerostructures $65.5B (2025), growing to $99B by 2031 at 7.6% CAGR. North America ~43%.
- SAM: U.S. defense and business jet Tier 1/2 structural outsourcing — roughly $5-8B.
- Market share: CPI at ~$80M revenue = well under 1% of SAM. Pure niche player.
Competitive Moat
Narrow but real, and program-specific:
- Switching costs (moderate): Once qualified on NGJ-MB, F-16 RI/DCC, or E-2D wing kits, CPI is locked in for the production run. Re-qualification costs millions and risks schedule.
- Certifications (moderate): AS9100, ITAR compliance, facility security clearances are meaningful barriers. But competitors have them too.
- Scale (weak): No scale advantages. Being small limits pricing power vs. the primes.
- IP (minimal): Build-to-print work generates no proprietary IP. Compac RF enclosures are closer to proprietary.
No brand moat, no network effects, no patent portfolio. This is a relationship-and-certification business.
Competitive Landscape
| Company | Revenue | Market Cap | Gross Margin | Notes |
|---|---|---|---|---|
| Triumph Group (TGI) | ~$1.3B | ~$2.4B | ~22% | Direct competitor at similar supply chain tier |
| Ducommun (DCO) | ~$800M | ~$2.3B | ~28% | Structures + electronics |
| Heico (HEI) | ~$4B | ~$35B | ~39% | Broader, IP + aftermarket moat |
| NWI Aerostructures (private) | Private | Private | -- | Direct competitor; CPI board member Rosenjack is CEO |
CPI is the smallest public player by a wide margin.
Industry Cycle Position
Defense spending is in a secular uptrend driven by great-power competition, NATO commitments, and bipartisan U.S. support. Early-to-mid innings of a 5-10 year defense spending supercycle. CPI-specific: transitioning from legacy programs (A-10, mature E-2D) to growth programs (NGJ-MB/LB, missiles, F-16 exports).
Secular Tailwinds
- Rising U.S. defense budgets (bipartisan support, 5-10yr+)
- Prime contractor outsourcing of manufacturing (5-10yr+)
- NGJ-MB/LB production ramp — generational EW modernization
- F-16 Block 70/72 export boom for allied nations
- Missile inventory rebuild post-Ukraine drawdowns
- Business jet deliveries remaining strong
Management
Executive Team
| Name | Title | Tenure | Background |
|---|---|---|---|
| Dorith Hakim | CEO, President & Director | Mar 2022 (~4 years) | Former Group VP at Parker Hannifin Aerospace ($1.9B spend, 11 divisions, 25 sites); prior VP at Triumph Group (4 divisions, then 7 operating companies); earlier career at Bell Helicopter, Vought, Sikorsky. EMBA TCU. Six Sigma Black Belt. |
| Robert Mannix | CFO & Secretary | Dec 2025 (~3 months) | 30+ years finance; former EVP/Chief Accounting Officer at West Technology Group; SVP/Controller at Verint Systems; started at Ernst & Young (11 years). CPA, Pace University. |
On Hakim: She inherited a mess — SEC investigations, four financial restatements, material weaknesses, bloated cost structure. Since March 2022: gross margins +170bps (19.6% to 21.3%), total debt cut 46% ($29.7M to $15.9M), SEC settlement completed, all material weaknesses remediated, won NGJ-MB Lots 4 & 5, NGJ-LB, missile wing assemblies, Collins RF enclosures, backlog grew to $510M. This is a genuine turnaround. She brought Parker Hannifin-grade manufacturing discipline to a small company that desperately needed it. The question is whether she'll stay long-term at a micro-cap or get recruited away.
On Mannix: Brand new (3 months). External hire to replace interim CFO Pamela Levesque (a board member who stepped in after prior CFO Philip Passarello resigned July 2025). Right background for CPI's needs — public company accounting, SOX compliance, audit, aerospace/defense familiarity from E&Y. Strong governance signal. Too early to judge performance.
CFO turnover note: Three CFOs in two years (Passarello resigned mid-year July 2025, Levesque interim, Mannix hired Dec 2025). Unusual but explained by circumstances. Passarello's departure during the A-10 writeoff year is worth noting — circumstances not publicly disclosed.
Board of Directors
| Name | Role | Independent? | Background | Committee |
|---|---|---|---|---|
| Carey Bond | Chairman | Yes | 30+ years aviation; former Sikorsky VP; Stony Point Group | Chair, Comp & HR |
| Terry Stinson | Vice-Chair | Yes | Former CEO Bell Helicopter Textron; EVP AAR Corp; Lennox International board | Chair, Strategic Planning |
| Dorith Hakim | Director | No (CEO) | See above | -- |
| Richard Caswell | Audit Chair | Yes | 22-year UTC career; former Sikorsky CFO; CPA; Price Waterhouse | Chair, Audit & Finance |
| Michael Faber | Director | Yes | CEO NextPoint Management; JD U of Chicago | Chair, Nom & Governance |
| Pamela Levesque | Director | Yes | 35+ years A&D; Aerojet Rocketdyne, AAR Corp CFO; served as CPI interim CFO | Comp & HR |
| Rick Rosenjack | Director | Yes* | CEO NWI Aerostructures (competitor); 38 years aerospace; Harvard/Wharton | Audit & Finance |
This is a legitimately strong board for a micro-cap. Four of seven have deep aerospace operating experience at meaningful scale (Sikorsky, Bell, AAR, Aerojet Rocketdyne). Not a vanity board. Majority independent (6 of 7). No dual-class shares, no poison pill, no staggered board. Shareholder-friendly governance — CPI would be relatively easy to acquire.
Bond-Rosenjack-NWI Interlock (Yellow Flag)
Carey Bond (Chairman) and Rick Rosenjack (Director) both serve on the boards of NWI Aerostructures and NWI Precision, both managed by Stony Point Group (Ken Glass family office). NWI Aerostructures is a direct competitor. Two of seven board members — including the Chairman — sit on a competitor's board. Rosenjack is NWI's CEO.
Conflict vectors: Information leakage (Rosenjack has access to CPI board materials), program bidding conflicts, and 29% board influence from the NWI ecosystem.
Mitigants: Both formally determined independent; no related-party transactions disclosed; niche industry = small talent pool; CPI and NWI may work on different programs.
Assessment: Yellow flag, not red. No evidence of self-dealing or information misuse. But the structural conflict is real and warrants monitoring.
Insider Ownership & Activity
- Aggregate insider ownership: ~21% — unusually high for a micro-cap, strong alignment signal
- Institutional ownership: ~26%
- Hakim: ~242K shares (~1.8%, ~$1.1M), accumulated through grants + some purchases at avg ~$2.76/share from 2022-2024. No recent open-market purchases. No selling.
- Bond: Open market purchase of 10,000 shares at $2.879 in June 2025 — bought with his own money near 52-week lows during the A-10 writeoff period. This is exactly what you want from a board chairman.
- No insider selling across any insider in the last 12 months.
- No 10b5-1 automatic selling plans.
Compensation
| Component | Hakim FY2024 |
|---|---|
| Base salary | $385,000 |
| Cash bonus | $222,900 |
| Equity grant (fair value) | $230,013 |
| Total | ~$838,000 |
Reasonable for a $81M revenue / $59M market cap company (~25th-50th percentile for micro-cap defense). Equity burn rate at 4.5% exceeds ISS benchmarks — elevated but manageable in dollar terms. Specific performance metrics driving incentive comp are not clearly disclosed — a transparency gap.
Capital Allocation Track Record (Grade: B+)
| Year-End | Total Debt |
|---|---|
| 2020 | $37.8M |
| 2021 | $34.2M |
| 2022 | $29.7M |
| 2023 | $25.2M |
| 2024 | $20.5M |
| Q3 2025 | $15.9M |
Five consecutive years of debt reduction, cutting total debt 58%. Below 3.0x debt/EBITDA for 8 consecutive quarters. This is disciplined deleveraging that directly benefits equity holders. No value-destroying M&A. No dilutive equity raises. Share count stable at 12.5-13.2M. The only knock: no opportunistic buybacks when the stock was at $2.00-2.50. But conserving cash to deleverage was probably the right call.
Corporate Structure
Clean. One public parent, one wholly-owned subsidiary (Compac Development Corp — RF/EMI enclosures). No SPVs, no off-balance-sheet structures, no undercapitalized affiliates.
SEC History & Litigation
SEC Settlement (June 2024): CPI settled over financial reporting violations spanning 2018-2022 — four restatements. Revenue recognition errors under ASC 606 (EAC mis-estimation on long-term contracts). Not alleged as fraud — characterized as reporting and controls failures. Cease-and-desist order accepted without admitting/denying. Material weaknesses fully remediated by Dec 2024 deadline. $400K penalty contingent on failure to remediate (effectively waived). The SEC chapter is closed, but the institutional scar of four restatements over six years is real.
NYSE Delisting Threat (2021): Received delisting notice; regained compliance after completing restatements. No personal enforcement actions against any current executive.
Management DD Verdict
| Dimension | Rating | Key Finding |
|---|---|---|
| Skin in the Game | Yellow | 21% aggregate is good; CEO's ~$1.1M modest but meaningful; Bond's open-market buy is positive; no insider selling |
| Holdings Concentration | Yellow | Rosenjack's primary affiliation is NWI (competitor, CEO); Bond sits on NWI boards |
| Shell / Cross-Holdings | Green | Clean structure. No related-party transactions. |
| Capital Allocation | Green | Excellent debt reduction. No value-destroying M&A. No dilution. |
| Compensation | Yellow | Reasonable absolute comp; 4.5% equity burn elevated; incentive metrics opaque |
| Governance | Green | Strong board, majority independent, no anti-takeover provisions |
| Litigation / Enforcement | Yellow | SEC settlement closed; four restatements is a real black mark even if remediated |
| Overall | B | Hakim is a credible turnaround CEO delivering on every dimension. Board is legitimate. NWI interlock is structural conflict but no misuse. SEC is a scar, not an open wound. |
Bottom line on management: You can trust these people with your capital, with appropriate position sizing. The main risk isn't governance — it's execution and customer concentration.
Financials
Income Statement & Margins
| Metric | FY 2022 | FY 2023 | FY 2024 | LTM (Sep '25) |
|---|---|---|---|---|
| Revenue | $83.3M | $86.5M | $81.1M | $71.6M |
| Revenue growth | -- | +3.8% | -6.2% | -16% (9mo) |
| Gross profit | $16.3M | $17.1M | $17.2M | $11.0M |
| Gross margin % | 19.6% | 19.7% | 21.3% | 15.3% |
| EBIT | $4.9M | $6.3M | $6.7M | $0.7M |
| EBIT margin % | 5.9% | 7.3% | 8.3% | 0.9% |
| Net income | $9.2M* | $17.2M* | $3.3M | ($0.6M) |
| EPS (diluted) | $0.74* | $1.38* | $0.26 | ($0.03) |
FY2022/2023 net income inflated by deferred tax asset valuation allowance reversals. Normalized EPS: FY2022 ~$0.30, FY2023 ~$0.25, FY2024 $0.29. TTM depressed by $8.1M in A-10 program writeoffs.
FY2024 is the cleanest read on underlying earnings power. TTM numbers are noise — the A-10 writeoff is non-recurring.
Quarterly Trend (Last 8 Quarters)
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.5M | $19.1M | $20.8M | $19.4M | $21.8M | $15.4M | $15.2M | $19.3M |
| Gross Margin | 17.4% | 18.8% | 24.5% | 21.7% | 20.0% | 10.4% | 4.6% | 22.3% |
| Net Income | $14.8M* | $0.5M | $1.1M | $0.7M | $1.0M | ($1.3M) | ($1.4M) | $1.1M |
Q1/Q2 2025 distorted by A-10 writeoffs ($2.1M + $2.3M). Q3 2025 is the clean business: margins expanding YoY on flat revenue. Fixed SG&A of ~$10M/year means incremental EBIT margins on revenue growth should be 30%+ once A-10 drag is gone. Real operating leverage.
Cash Flow & Balance Sheet
| Metric | FY 2022 | FY 2023 | FY 2024 | LTM (Sep '25) |
|---|---|---|---|---|
| Operating cash flow | $0.9M | $3.9M | $3.6M | $1.3M |
| Capex | ($0.04M) | ($0.14M) | ($0.40M) | ($0.14M) |
| Free cash flow | $0.9M | $3.8M | $3.2M | $1.2M |
| FCF margin % | 1.1% | 4.4% | 3.9% | 1.6% |
| Net debt | $25.9M | $20.1M | $15.0M | $15.4M |
| Net debt / EBITDA | ~3.7x | ~2.7x | 2.2x | N/M |
| ROIC | ~14% | ~16% | ~16% | Depressed |
Debt trajectory is the star of the show. ROIC of ~16% comfortably exceeds estimated WACC of ~10-12%. CPI is creating value on invested capital when operating normally.
Forward Estimates
- FY2025E: Revenue ~$70-75M (A-10 drag), gross margin ~18-20%, net income ~$0-2M. This is the trough year.
- FY2026E: Revenue should recover to $80-90M as NGJ-MB Lot 4/5, NGJ-LB, and missile assemblies ramp. $510M backlog provides the fuel.
- FY2027E: If NGJ-MB hits full-rate and new programs contribute, revenue could reach $90-100M+ with 21-22% gross margins. EBITDA ~$10-12M. At 10x EV/EBITDA = $7.50-8.00/share.
Dilution Risk
Low. Share count stable at 12.5-13.2M over 5 years. No ATM program, no shelf registration actively in use. No material convertibles or warrants. CPI generates $3-4M FCF annually in normal operations — self-funding, no equity raise needed.
Catalysts & Risks
Near-Term Catalysts (0-12 months)
- Q4 2025 / FY2025 earnings (late March 2026): A-10 drag fully absorbed. If Q4 mirrors Q3's 22% gross margin, the full-year story improves dramatically. First clean data point.
- NGJ-MB Lot 5 production ramp: Manufacturing started; revenue should accelerate through 2026-2027.
- Missile wing assembly deliveries begin 2026: New revenue stream.
- Potential new contract awards: Any new wins are catalytic given the small revenue base.
Medium-Term Catalysts (1-3 years)
- NGJ-LB production progression: If it moves from prototype to production, CPI is positioned for a much larger L3Harris contract.
- Revenue rebound to $90-100M: Backlog conversion should drive recovery in 2026-2027.
- Margin expansion: Higher-margin NGJ pod work replacing lower-margin legacy programs.
- Continued debt reduction: At current FCF trajectory, could be net-debt-free within 3-4 years.
- Acquisition target potential: $510M backlog + defense certs + $70-80M revenue at $59M market cap makes CPI potentially attractive to larger aerostructure players.
Key Contracts & Awards
| Contract | Counterparty | Value | Status | Revenue Impact |
|---|---|---|---|---|
| NGJ-MB Lot 5 | Raytheon (RTX) | $42.3M NTE | Awarded Nov 2025 | Deliveries from 2027 |
| NGJ-MB Lot 4 | Raytheon (RTX) | $33.4M max | Deliveries underway H2 2025 | Revenue flowing |
| NGJ-MB Follow-on | Raytheon (RTX) | $12M NTE ($6M funded) | Awarded Mar 2026 | Near-term |
| NGJ-LB | L3Harris (LHX) | $12.1M NTE | Awarded Dec 2024 | Deliveries 2025-2027 |
| F-16 Block 70/72 | Lockheed Martin (LMT) | $9M | Awarded; through 2028 | Flowing |
| Missile Wings | Raytheon (RTX) | Undisclosed | Deliveries start 2026 | New stream 2026+ |
| Phenom 300 Inlets | Embraer (ERJ) | $4.2M | Awarded Feb 2026 | Near-term |
| RF/EMI Enclosures | Collins/RTX | Undisclosed | Follow-on Mar 2026 | Through mid-2027 |
Risk Matrix
| Risk | Likelihood | Mitigants | Closable? |
|---|---|---|---|
| Customer concentration (Raytheon/RTX) | High | NGJ-LB diversifies to L3Harris; F-16 to Lockheed; Embraer provides commercial offset | Only managed |
| Single-facility risk | Medium | Long Island is low natural-disaster-risk; well-equipped 171K sq ft | Not closable unless second site opens |
| Program termination (A-10 repeat) | Medium | $510M diversified backlog across multiple programs | Partially closable via diversification |
| Revenue timing / backlog conversion | Medium | Multiple programs at different stages provide diversification | Closable as new programs ramp |
| SEC / internal controls recurrence | Low | All material weaknesses remediated; new CFO hired; full SOX remediation | Effectively closed but monitoring required |
| Micro-cap liquidity | Medium | NYSE American listed; avg volume ~177K shares/day | Structural, only managed |
Key-Person Risk
Dorith Hakim is the key person. Departure would be disruptive. Board has relevant aerospace depth (Bond, Stinson, Rosenjack) as bench. No public succession plan. Her ~$1.1M equity stake provides some retention but isn't life-changing wealth.
Emerging Threats
- Additive manufacturing: Could replace some machined metal structures, but 5-10 year horizon for primary aircraft structures.
- Composites shift: Long-term metal-to-composite trend is real, but military platforms remain heavily metallic.
- Consolidation: CPI could be acquired or squeezed out. Also makes CPI a potential acquisition target.
- Prime in-sourcing: Trend is outsourcing; reversal unlikely given current capacity constraints.
Decision Log
Recommendation: BUY (scale in)
Conviction: Medium Position size: 1.5-2.5% of portfolio Holding period: 12-24 months
Entry strategy: Scale in over 2-3 purchases:
- Initial entry (0.5-1.0%): At $4.40-4.50 or pullback to $3.80-4.00
- Add #1 (0.5-0.75%): After Q4 2025/FY2025 earnings confirm normalized margins above 20%
- Add #2 (0.5-0.75%): On any new material contract win or revenue inflection
Exit criteria:
- Target exit: $6.50-7.50
- Thesis-broken exit: $2.80 hard stop
- Event exits: NGJ-MB cancellation/delay, loss of top-3 customer, another SEC issue, CEO departure without succession
Behavioral traps audit:
- FOMO: No — stock well below historical highs, no frenzied momentum
- Confirmation bias: Possible — thesis built on forward-looking backlog conversion; A-10 shows backlog doesn't always convert cleanly
- Narrative seduction: Yellow flag — "$510M backlog defense turnaround" is compelling narrative, but financials back it up
- Recency bias: Don't extrapolate Q3 2025's 22.3% gross margin as permanent; check multiple quarters
Technical Setup (mid-March 2026)
- Stock at ~$4.47, likely above 50-day and near 200-day MA. Recovering uptrend from $2.02 low.
- Higher highs and higher lows since mid-2025. Stage 2 breakout setup (Weinstein framework).
- Support: $3.50-3.80. Resistance: $4.65-5.00. Key level: $5.40 (52-week high).
- Volume above average recently, indicating accumulation. But thin for a micro-cap — large orders move the price.
- Technical verdict: Supportive of buying, but stock has doubled from lows. Better risk/reward on pullback to $3.80-4.00 or confirmed breakout above $4.65.
Pre-Buy Scorecard
| Question | Answer |
|---|---|
| Can I state the thesis clearly? | Yes |
| Do I understand the business? | Yes |
| Are the financials healthy? | Yes — FCF positive, debt declining, ROIC > WACC |
| Is the valuation reasonable? | Yes — meaningful peer discount |
| Behavioral traps? | No — main risk is narrative seduction |
| Technicals support buying? | Mostly — ideally pullback or post-earnings entry |
| Position sized appropriately? | Yes — 1.5-2.5% reflects micro-cap risk |
| Clear exit plan? | Yes |
Ownership & Sentiment
- Insiders: ~21% (strong alignment)
- Institutions: ~26% (low but normal for $59M market cap)
- Float: ~79%
- Short interest: 274K shares (2.3% of float), 1.55 days to cover — minimal
- Analyst coverage: Essentially none. $59M market cap is below institutional radar. This is an information edge, not a red flag.
SEC Filing Review
- 10-K FY2024: Revenue $81.1M, net income $3.3M, adj EBITDA $7.8M, total debt $17.4M. Clean audit opinion. $510M backlog.
- 10-Q Q3 2025: A-10 writeoff impact fully reflected; Q3 standalone improving. Debt at all-time low $15.9M.
- SEC Settlement (June 2024): Closed. Remediated. No penalty assessed.
- No going concern language. No auditor changes. No activist positions (no 13D filings).
- Insider transactions: Bond open-market buy at $2.88 (June 2025). No selling. Director RSU grants routine.
- Guidance: Company does not provide formal guidance. $510M backlog is the primary forward indicator.
Sources
- CPI Aerostructures IR
- CPI Aero FY2024 Results
- CPI Aero Q3 2025 Results
- NGJ-MB Lot 5 Award
- NGJ-LB L3Harris Contract
- Raytheon $6M Pod Follow-on Orders
- Embraer $4.2M Order
- Robert Mannix CFO Appointment
- SEC Settlement
- Collins Aerospace RF/EMI Orders
- Stock Analysis - CVU
- Aerostructures Market Size (GMInsights)
- Carey Bond Open Market Purchase (GuruFocus)
- Dorith Hakim Insider Trading (GuruFocus)
- CPI Aero Board of Directors
- NWI Aerostructures Leadership
- Stony Point Group Portfolio
- SEC Enforcement Action
Topics
- defense-technology
Source updates (auto-maintained)
Drop/Defense (Jul 25, 25) - 20250721_Atrium_Defence.03
Atrium Research's July 2025 thematic note lists CVU as a U.S.-listed small-cap beneficiary of the multi-year NATO/defence spending cycle, citing strong revenue growth, record backlogs, and expanding margins as the core rationale for the sector.
Relevant to your thesis: Corroborates the secular defence tailwind underpinning the bull case, though the report covers CVU only in passing as part of a broad basket — no program-level or financial detail specific to NGJ-MB or backlog conversion.
Source: dropfile://Defense/20250721_Atrium_Defence.03.pdf